April 20, 2021 – The Class Action will be discontinued
The plaintiffs of the proposed class action,
Dowe et al v The Attorney General of Canada, are bringing a motion seeking the court’s approval to discontinue the class action proceedings, in order to pursue their own claims against the Government of Canada in Federal Court. If the motion for discontinuance is approved by the Ontario Superior Court of Justice, then the proposed class action will be concluded. It will not be proceeding to trial and there will be no judgment or settlement in that action, either for or against the proposed class.
It is important to know that any limitation periods that were suspended in favour of class members while the proposed class action is outstanding will start to run again from the effective date of the discontinuance.
This could affect your rights if you want to bring your own claim.
Class members who want to bring a lawsuit for injuries they believe they sustained from the ordered ingestion of Mefloquine while a member of the Canadian Armed Forces are advised to speak with a lawyer as soon as possible to learn about their rights.
PLEASE NOTE:
If you have already been named as a plaintiff in a Federal Court action, or if you have already signed a retainer, then this discontinuance does NOT affect you.
For more information, you can contact class counsel at:
Email:
MEFLOQUINE@HSHLAWYERS.COM
Phone: 1-877-771-7006